Inauguration of Lund's new ATMP infrastructures

Welcome to a full day about the ATMP infrastructures available in Lund!

The event is fully booked but you may still sign-up to attend the event online: 

• Register to attend the event online here.
• Download event program (PDF)

Program "Advancing science and innovation for cell and gene therapies" 

08:30 Breakfast & mingle

09:00 Welcome

Lisa Kirsebom, science journalist and moderator

09:05 Keynote

Frank Staal, Professor of Stem Cell Biology, Leiden University Medical Center

09:45 Dawn: Pioneering beginnings

”REPLACING DOPAMINE NEURONS IN PARKINSON’S PATIENTS: THE PIONEERING YEARS”
Olle Lindvall, Senior Professor of Neurology, Lund University
Anders Björklund, Senior Professor of Neurobiology, Lund University

”STEM-PD - hESC DERIVED DOPAMINERGIC NEURON PROGENITORS FOR PARKINSON’S DISEASE”
Malin Parmar, Professor of Cellular Neuroscience and Director, Lund Stem Cell Center, Lund University

PANEL DISCUSSION
Malin Parmar, Olle Lindvall, and Anders Björklund moderated by Lisa Kirsebom

”WHY ATMPs IN LUND AND SKÅNE?”
Stefan Jovinge, President of Research, Education, Development, and Innovation, Skåne University Hospital

10:25 Ribbon cutting

Erik Renström, Vice-Chancellor, Lund University and Carl Johan Sonesson (M), Chair, Regional Executive Board in Skåne

10:40 Fika break

11:10 Present: Current clinical applications

”GENE THERAPY IN METACHROMATIC LEUKODYSTROPHY – THE NORDIC TREATMENT CENTER IN LUND”
Erik Eklund, Head of the Section of Pediatric Neurology, Pulmonology and Metabolism, Skåne Children's Hospital

”FACILITATING CLINICAL TRIALS WITH ATMPS”
Ana Carneiro, Senior Consultant, Oncology, Skåne University Hospital

”IN VIVO GENE THERAPY FOR HEREDITARY FRONTAL LOBE DEMENTIA”
Hjálmar Bjartmarz, Neurosurgeon, Skåne University Hospital

PANEL DISCUSSION
 – Erik Eklund, Ana Carneiro, and Hjálmar Bjartmarz moderated by Lisa Kirsebom

11:55 Lunch

12:55 On the Horizon

”HACKING CANCER CELLS TO BECOME GOOD: A SCIENCE COMMUNICATOR’S GUIDE TO CELLULAR REPROGRAMMING” Luís Oliveira, Doctoral Student, Lund University

”FROM SCIENCE TO START UP: DEVELOPING A GENE THERAPY FOR A RARE BLOOD DISORDER”
Johan Flygare, Associate Professor, Lund University

”DEVELOPING A PLURIPOTENT-DERIVED CELL THERAPY FOR CHOLINERGIC DEMENTIAS”
Agnete Kirkeby, Associate Professor, Lund University

”DEVELOPMENT OF HYPER-FUNCTIONAL IPS CELL DERIVED NK CELLS FOR ADOPTIVE CELL IMMUNOTHERAPY”
Niels-Bjarne Woods, Associate Professor, Lund University

13:35 Fika break

14:25 Research today, therapy tomorrow: How do we get there?

”ATMP MODEL BY LUND”
Anna Falk, Professor of Neural Stem Cells and Director, LU-ATMP, Lund University

”PRE-GMP FACILITY”
Elias Uhlin, Director, Pre-GMP-Facility, Lund University

”ATMP CENTER”
Gisela Helenius, Director, ATMP Center, Skåne University Hospital

”iACTORS”
Ulrika Ringdahl, CEO, SmiLe Venture Hub

PANEL DISCUSSION
Anna Falk, Elias Uhlin, Gisela Helenius, and Ulrika Ringdahl moderated by Lisa Kirsebom

14:55 Fika break

15:25 Industry, innovation and insights

XINTELA
Evy Lundgren-Åkerlund, CEO, Xintela AB

ASGARD THERAPEUTICS
Cristiana Pires, CEO, Asgard Therapeutics

NOVO NORDISK FOUNDATION CELLERATOR
Thomas H.R. Carlsen, CEO, Novo Nordisk Foundation Cellerator

ERLY THERAPEUTICS
Alex Evilevitch, Professor of Virus Biophysics, Lund University

PANEL DISCUSSION
Evy Lundgren-Åkerlund, Cristiana Pires, and Thomas H.R. Carlsen

16:40 Summary and reflections

Sarah Lidé, Deputy CEO, Medicon Village Innovation

16:45 – 19:00 Mingle